Rezolute Stock (NASDAQ: RZLT) stock price, news, charts, stock research, profile.
Open | $3.650 |
Close | $2.860 |
Volume / Avg. | 940.007K / 356.870K |
Day Range | 2.670 - 3.679 |
52 Wk Range | 0.720 - 3.690 |
Market Cap | $115.166M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 56 |
Short Interest | 1.49% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Rezolute (NASDAQ: RZLT) through any online brokerage.
Other companies in Rezolute’s space includes: Molecular Partners (NASDAQ:MOLN), Zura Bio (NASDAQ:ZURA), Syros Pharmaceuticals (NASDAQ:SYRS), Vistagen Therapeutics (NASDAQ:VTGN) and Adicet Bio (NASDAQ:ACET).
The latest price target for Rezolute (NASDAQ: RZLT) was reported by JMP Securities on Friday, April 19, 2024. The analyst firm set a price target for 7.00 expecting RZLT to rise to within 12 months (a possible 143.90% upside). 14 analyst firms have reported ratings in the last year.
The stock price for Rezolute (NASDAQ: RZLT) is $2.87 last updated April 23, 2024 at 7:54 PM EDT.
There are no upcoming dividends for Rezolute.
Rezolute’s Q3 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Rezolute.
Rezolute is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.